MRI scan to track response in colorectal liver metastases
Part of Cancer, Digestive system clinical trials.
This study uses a special MRI scan to see how colorectal cancer in the liver responds to planned chemotherapy before and after surgery. It may help doctors better measure treatment success and plan care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have colorectal cancer that has spread to the liver (liver metastases) and you have not had chemotherapy for this liver disease yet
- Your treatment plan must include starting chemotherapy for liver metastases (FOLFOX, FOLFIRI, or FOLFOXIRI), with or without a biologic medicine
- You have at least one liver metastasis that measures 1 centimeter or larger
- You are able to have follow-up visits and scans at MD Anderson before surgery and after surgery
- You cannot have had pre-surgery chemotherapy for these liver metastases, and you will not have radiation, ablation, or other non-surgical liver treatments
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses MRI scans to study how colorectal cancer that has spread to the liver grows. It may help doctors choose better treatments.
This trial compares two types of MRI scans to see if one is as good as the other for finding and tracking liver tumors in people with colorectal cancer. You can join if you are starting chemotherapy or need your cancer checked.
This study checks whether a special MRI scan (DW-MRI) can spot liver metastases early in people with high-risk colorectal cancer. Finding metastases sooner may help doctors choose the right treatment path.
This study uses a special MRI to look at liver metastases from colorectal cancer, aiming to see how well the MRI can see the tumors and how they respond to chemotherapy. If you qualify, you'll have an extra MRI before starting chemotherapy, which might help doctors understand the cancer better.
This trial studies how well MRI can evaluate liver metastases (spread to the liver) from colorectal cancer. If you have measurable liver lesions, your MRI results may help doctors better track and plan care.
This trial studies an MRI technique using a contrast dye (gadopetate/gadolinium) to better look at liver lesions that may be colon cancer spread. It may help doctors more accurately assess which liver tumors are present and guide next steps.
Hear when a new Metastatic Colorectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.